| Literature DB >> 32714553 |
Chu-Pin Pai1, Chih-Ming Lin1, Yi-Chen Yeh2, Chien-Sheng Huang1,3, Biing-Shiun Huang1.
Abstract
A 63-year-old man presented with bilateral ptosis, and detailed evaluation confirmed ocular myasthenia gravis with three anterior mediastinal masses on computed tomography (CT) of the chest. Extended thymectomy was performed, and pathology revealed two thymic carcinoma and one thymoma. After surgery, the patient is free from recurrence. Synchronous triple thymic carcinomas and thymoma have not been reported. The finding of this case report supports the hypothesis of malignant transformation of thymoma to thymic carcinoma. Thymic carcinoma should be considered in the differential diagnosis of multiple thymic tumours, and extended thymectomy should be the treatment of choice.Entities:
Keywords: Extended thymectomy; myasthenia gravis; thymic carcinoma; thymoma
Year: 2020 PMID: 32714553 PMCID: PMC7376331 DOI: 10.1002/rcr2.629
Source DB: PubMed Journal: Respirol Case Rep ISSN: 2051-3380
Figure 1Three separate anterior mediastinal nodules located at the right hilar (A, 2.3 × 1.2 cm), pre‐cardiac (B, 1.4 × 0.9 cm), and infra‐innominate vein space (C, 0.6 × 0.5 cm), respectively. The three anterior mediastinal nodules were all round or ovoid in shape and were smooth in contours and there were no enlarged lymph nodes nearby identified. Two thymic tumours (A and B) with a non‐specific small lymph node (C) was impressed preoperatively in the present case.
Figure 2Grossly, three separate nodules were found in the extended thymectomy specimen. (A) Microscopically, sections of tumour A show picture of thymoma, which are immunoreactive for p40, and non‐reactive for CD5 and CD117 with scattered terminal deoxynucleotidyl transferase (TdT)‐positive lymphocyte inside the tumour. (B, C) Sections of both tumour B and tumour C show squamous cell carcinoma, non‐keratinizing, which are immunoreactive for p40, focally immunoreactive for CD5 and CD117, with negative immunostaining for terminal deoxynucleotidyl transferase (TdT) in the tumour.